Product
CST-2
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
AGILE: Seamless Phase I/IIa Platform for the Rapid Evaluation of Candidates for COVID-19 TreatmentStatus: Active (not recruiting), Estimated PCD: 2023-12-18
1 clinical trial
1 indication